Add BrightSurf on Google Email

Napoleone Ferrara, MD, receives 2026 Yergin Family International Prize for Biomedical Research

Napoleone Ferrara, MD, has been awarded the 2026 Yergin Family International Prize for Biomedical Research for his discovery of vascular endothelial growth factor (VEGF), a molecule that plays a key role in abnormal blood vessel growth in cancer and blinding eye diseases. His research led to the development of treatments that have bene...

Could earlier recognition of cerebral visual impairment in the NICU help more children thrive?

A new clinical practice guideline aims to standardize the identification and management of infants at increased risk for cerebral visual impairment (CVI). The guideline recommends comprehensive ophthalmologic evaluation and referral to developmental services within the first six months of life to access interventions as early as possible.

SourceMass General Brigham·JournalNature·TypeSurvey·DateSep 29, 2026

Nearly one in five people with sight loss report encountering bogus treatments

A study of 955 adults with diagnosed eye conditions found that nearly 19% reported receiving or encountering treatments they believed to be 'bogus'. The survey highlights the importance of clear and evidence-based communication between clinicians and patients in navigating the complex environment of health information and commercial tr...

SourceUniversity College London·JournalJAMA Ophthalmology·TypeSurvey·DateSep 24, 2026

New Trinity research suggests a simple pill could prevent sight loss in common form of diabetes-driven eye condition

Researchers have found that an oral medication called Danegaptide can protect against vision-threatening damage in Non-Proliferative Diabetic Retinopathy (NPDR), a leading cause of blindness in working-age adults. The study highlights a new therapeutic approach that could replace or complement frequent, invasive eye injections for mill...

SourceTrinity College Dublin·JournalScience Translational Medicine·DateSep 23, 2026

SUNY College of Optometry foundation features AI and myopia leaders at inaugural Advancing Vision Summit on September 25

The summit explores the intersection of AI, eye care, and public health, with a focus on artificial intelligence, oculomics, population health, and myopia management. The event brings together leaders from healthcare, technology, and optometry to discuss innovative approaches to improve eye health and expand access to care.

A blind retina isn't silent and its noise may be getting in the way of restoring sight

A team at the Hôpital ophtalmique Jules-Gonin recorded the retina's spontaneous electrical activity in patients with retinitis pigmentosa, revealing abnormal rhythms. The findings suggest that the retina is not as silent as previously thought and that measuring its activity could help guide sight-restoring therapies. The study's result...

SourceHôpital ophtalmique Jules-Gonin, Fondation Asile des aveugles·JournalNature·TypeRandomized controlled/clinical trial·DateSep 14, 2026

Cataract surgery continues to improve across Europe

The latest figures from the European Registry of Quality Outcomes for Cataract and Refractive Surgery show significant improvements in safety and efficacy, with complications such as posterior capsule rupture occurring at a low rate. The registry has recorded nearly five million cataract surgeries, with the most common procedure being ...

SourceEuropean Society of Cataract and Refractive Surgeons·TypeData/statistical analysis·DateSep 14, 2026

High myopia control is not only about axial length: study suggests posterior scleral reinforcement may slow early fundus changes in children

A three-year study found that posterior scleral reinforcement slowed macular fundus tessellation and preserved subfoveal choroidal thickness in children with progressive high myopia. The researchers suggest that PSR may help delay early myopic maculopathy-related changes, possibly through mechanisms beyond axial elongation.

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateAug 10, 2026

A new way to examine the cornea. Nine points at once

Researchers developed a prototype imaging system that can simultaneously track the cornea's mechanical response at nine locations, allowing for more accurate assessment of corneal biomechanics. This technology has the potential to improve early detection and monitoring of disorders like keratoconus.

SourceInstitute of Physical Chemistry of the Polish Academy of Sciences·JournalBiomedical Optics Express·TypeExperimental study·DateJul 28, 2026

IBEC-led consortium develops light-activated drugs that restore sight in blind mice

A new class of photoswitchable small molecule drugs has been developed to restore key visual functions in animal models of blindness. These compounds mimic the function of photoreceptor cells and show remarkable effectiveness at restoring sight using a simple and potentially patient-friendly approach.

SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalJournal of the American Chemical Society·TypeExperimental study·DateJul 15, 2026

How can patients with irregular corneas see more clearly? Multicenter study shows short-term vision improvement with a four-zone scleral lens

A multicenter study found that patients with irregular corneas achieved significant visual acuity improvements after wearing a four-zone scleral lens for three months. The lenses showed encouraging fitting efficiency and patient comfort, with minimal adverse events reported.

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateJul 13, 2026

Peer-reviewed study confirms CVI range is a valid, reliable tool for assessing cortical visual impairment in children

A new study published in Ophthalmology Science has confirmed that The CVI Range Assessment is a valid and reliable instrument for evaluating functional vision in children with Cortical Visual Impairment (CVI). This finding provides evidence that the widely used assessment meets rigorous clinical and psychometric standards, offering a s...

SourceThe Children’s Home of Pittsburgh·JournalOphthalmology Science·DateJul 13, 2026

Eye problems after COVID-19 can now be explained

A study from Linköping University finds that mild COVID-19 can lead to long-term eye problems, including abnormal pupil function and strabismus, affecting daily life. Researchers developed a diagnostic model to detect these issues, which may lead to effective treatment.

SourceLinköping University·JournalNature Communications·TypeObservational study·DateJul 8, 2026

Seeing through optical noise: a sharper way to image the eye

The STOC-T technology resolves optical noise in eye imaging by fundamentally changing the way imaging data is collected, resulting in sharper images and improved diagnostic accuracy. This new approach addresses the problem earlier, before image construction, rather than relying on post-processing algorithms.

SourceInstitute of Physical Chemistry of the Polish Academy of Sciences·JournalJournal of Biomedical Optics·TypeExperimental study·DateJun 24, 2026

Seeing clearly is not the whole story: A VISUMAX 800 KLEx study tracks early visual quality after myopia surgery

A recent study published in Eye Discovery evaluated the early visual quality after KLEx surgery using the VISUMAX 800 platform. The study found excellent safety and efficacy outcomes, with most subjective visual symptoms improving over time. However, glare symptoms persisted longer than expected, highlighting the need for preoperative ...

SourceEye Discovery·JournalEye Discovery·TypeObservational study·DateJun 23, 2026

Medical School researcher awarded $2.2 million NIH grant to study retinal disease causes, potential treatments

A University of Minnesota Medical School research team has been awarded a 4-year, $2.2 million grant to better understand the underlying causes of retinal diseases like age-related macular degeneration (AMD) and develop new treatments. The focus is on fibulin-3, an extracellular matrix protein that causes blinding eye diseases.

The precise bioenergetic map of ocular tissues: Research on TCA cycle intermediate distribution and sexual dimorphism

The study utilizes high-sensitivity LC-MS to quantify TCA cycle intermediates in mouse ocular tissues, revealing dual differences in metabolic characteristics based on spatial distribution and biological sex. Key findings include tissue-specific metabolic phenotypes and sexual dimorphism of metabolic profiles.

SourceEye Discovery·JournalEye Discovery·TypeComputational simulation/modeling·DateMay 11, 2026

A clinical reveals that aniridia causes a progressive loss of corneal sensitivity

A study published in Cornea reveals that aniridia not only alters corneal structure but also affects sensory nerve function, leading to a progressive decline in corneal sensitivity. In adulthood, patients experience difficulty distinguishing stimulus intensity and reduced tear production, compromising eye defense mechanisms.

SourceUniversidad Miguel Hernandez de Elche·JournalCornea·TypeRandomized controlled/clinical trial·DateFeb 27, 2026

Bridging eye disease care with addiction services

Researchers found that patients with substance use disorder received life-saving treatments only when addiction consult services were involved. Fentanyl use was associated with dramatically worse visual outcomes, highlighting the importance of addressing underlying conditions alongside acute medical problems.

SourceMass Eye and Ear·JournalOphthalmology Retina·TypeObservational study·DateFeb 10, 2026

Unexpected partial recovery of natural vision observed after intracortical microstimulation in a blind patient

A blind patient partially recovered natural vision through electrical stimulation of the visual cortex, independent of the implant. The recovery was sustained over time and remained even after the device was removed, suggesting individual factors may have contributed to this outcome.

SourceUniversidad Miguel Hernandez de Elche·JournalBrain Communications·TypeExperimental study·DateFeb 3, 2026

Insights from brain’s waste-flushing system may improve diagnosis of idiopathic intracranial hypertension

Researchers used MRI analysis to measure glymphatic system activity, finding changes related to IIH stage and pressure levels. The findings suggest a noninvasive test could diagnose IIH more reliably, improving treatment options for patients with symptoms including headaches and vision loss.

SourceMass General Brigham·JournalJournal of Neuro-Ophthalmology·TypeExperimental study·DateJan 27, 2026